sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Biotechnology Europe Drug Modelling Software Market...

Europe Drug Modelling Software Market Forecast to 2027 – COVID-19 Impact and Analysis – by Product Type (Database, Software, and Others); and Application (Drug Discovery and Development, Computational Physiological Medicine, Disease Modelling, Medical Imaging, Predictive Analysis of Drug Targets, Simulation Software, Cellular Simulation, and Others)

TIPRE00013989 | Pages: 108 | Biotechnology | Sep 2020 | Type: Regional | Status: Published

Market Introduction

Drug modelling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key role in the development of novel drugs. Software based methods such as molecular modelling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. In addition, appropriate implementation of these techniques may help in reducing cost of drug designing and development.


Get more information on this report :



Market Overview and Dynamics

The Europe drug modelling software market is expected to reach US$ 3,215.94 million by 2027 from US$ 1,826.99 million in 2019. The market is anticipated to grow at a CAGR of 7.6% during 2019–2027. The increasing adoption of in-silico modelling tools in drug discovery, and increasing economic burden of drug discovery are the major factors expected to boost the growth of the drug modelling software market in Europe. However, the market is likely to get impacted by the risk factor such as lack of data standardization during the forecast period.

Key Market Segments

In terms of product type, the software segment accounted for the largest share of the Europe drug modelling software market in 2019. In terms of application, drug discovery and development segment accounted for the largest share of the Europe drug modelling software market in 2019.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the Europe drug modelling software market report are the European Federation of Pharmaceutical Industries and Associations (EFPIA), European Medicines Agency (EMA), and others.

Reasons to buy report

  • It provides understanding of the Europe, drug modelling software market landscape and identifies drug modelling software market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe drug modelling software market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the drug modelling software market by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of drug modelling software market performance of various segments pertaining to the Europe drug modelling software market.
  • It provides drug modelling software market revenue forecast of the market based on various segments for the period from 2019 to 2027.

EUROPE DRUG MODELLING SOFTWARE MARKET SEGMENTATION

By Product Type

  • Database
  • Software
  • Others

By Application

  • Drug Discovery and Development
  • Computational Physiological Medicine
  • Disease Modeling
  • Medical Imaging
  • Predictive Analysis of Drug Targets
  • Simulation Software
  • Cellular Simulation
  • Others

By Country

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Company Profiles

  • Crown Bioscience Inc (JSR life science)
  • Genedata AG
  • Biognos AB
  • Dassault Systèmes
  • Acellera

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Drug Modelling Software Market – By Product Type

1.3.2        Europe Drug Modelling Software Market – By Application

1.3.3        Europe Drug Modelling Software Market – By Country

2.           Europe Drug Modelling Software Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Drug Modelling Software Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Drug Modelling Software Market - Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Drug Modelling Software Market -  Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Adoption of Modelling Tools in Drug Discovery

5.1.2        Increasing Economic Burden of Drug Discovery

5.2         Key Market Restraints

5.2.1        Lack of Data Standardization

5.3         Key Market Opportunities

5.3.1        Strategic Activities by Market Players

5.4         Future Trends

5.4.1        Growing Adoption of Artificial Intelligence in Drug Discovery

5.5         Impact analysis

6.           Drug Modelling Software Market – Europe Analysis

6.1         Europe Drug Modelling Software Market Revenue Forecasts and Analysis

7.           Europe Drug Modelling Software Market Analysis and Forecasts To 2027 – By Product Type

7.1         Overview

7.2         Europe Drug Modelling Software Market, By Product Type 2019 & 2027 (%)

7.2.1        Europe Drug Modelling Software Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)

7.3         Database

7.3.1        Overview

7.3.2        Europe Database Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Software

7.4.1        Overview

7.4.1.1          Europe Software Revenue and Forecasts to 2027 (US$ Mn)

7.5         Other Product Types

7.5.1        Overview

7.5.2        Europe Other Product Types Market Revenue and Forecast to 2027 (US$ Mn)

8.           Europe Drug Modelling Software Market Analysis and Forecasts To 2027 – By Application

8.1         Overview

8.2         Europe Drug Modelling Software Market, By Application 2019 & 2027 (%)

8.2.1        Europe Drug Modelling Software Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3         Drug Discovery and Development

8.3.1        Overview

8.3.2        Europe Drug Discovery and Development Market Revenue and Forecast to 2027 (US$ Mn)

8.4         Computational Physiological Medicine

8.4.1        Overview

8.4.2        Europe Computational Physiological Medicine Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Disease Modelling

8.5.1        Overview

8.5.2        Europe Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Medical Imaging

8.6.1        Overview

8.6.2        Europe Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Predictive Analysis of Drug Targets

8.7.1        Overview

8.7.2        Europe Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

8.8         Simulation Software

8.8.1        Overview

8.8.2        Europe Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

8.9         Cellular Simulation

8.9.1        Overview

8.9.2        Europe Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

8.10      Others

8.10.1     Overview

8.10.2     Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Drug Modelling Software Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         Europe Drug modelling software Market Revenue and Forecasts To 2027

9.1.1        Overview

9.1.2        Europe: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        Europe: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.4        Europe: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.5        Europe: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

9.1.6        Germany: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          Germany: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          Germany: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.6.3          Germany: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.7        France: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          France: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          France: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.7.3          France: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.8        UK: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          UK: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          UK: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.3          UK: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.9        Italy: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1          Italy: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2          Italy: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.9.3          Italy: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.10     Spain: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.1       Spain: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.2       Spain: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.10.3       Spain: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.        Impact of COVID-19 Pandemic on Europe Drug Modelling Software Market

10.1      Europe: Impact Assessment of COVID-19 Pandemic

11.        Company Profiles

11.1      Genedata AG

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Biognos AB

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Dassault Systèmes

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Acellera

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.5      Crown Bioscience Inc (JSR life science)

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Drug Modelling Software Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)

Table 2.             Europe Drug Modelling Software Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.             Europe: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             Europe: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             Germany: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Germany: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 7.             France: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             France: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             UK: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          UK: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          Italy: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Italy: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.          Spain: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Spain: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Glossary of Terms, Drug Modelling Software Market

 

 

LIST OF FIGURES

Figure 1.           Drug Modelling Software Market Segmentation

Figure 2.           Europe Drug Modelling Software Market Overview

Figure 3.           Software Segment Held Largest Share of Drug Modelling Software Market

Figure 4.           UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Europe Drug Modelling Software Market - Leading Country Markets (US$ Mn)

Figure 6.           Drug Modelling Software Market - Europe PEST Analysis

Figure 7.           Drug Modelling Software Market Impact Analysis of Driver and Restraints

Figure 8.           Europe Drug Modelling Software Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Europe Drug Modelling Software Market, By Product Type 2019 & 2027 (%)

Figure 10.        Europe Database Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Europe Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Europe Other Product Types Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Europe Drug Modelling Software Market, By Application 2019 & 2027 (%)

Figure 14.        Europe Drug Discovery and Development Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Europe Computational Physiological Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Europe Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Europe Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Europe Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Europe Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Europe Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Europe: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        Europe: Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)

Figure 24.        Europe: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

Figure 25.        Germany: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        France: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        UK: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Italy: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Spain: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Impact of COVID-19 Pandemic in European Country Markets

 

The List of Companies - Europe Drug Modelling Software Market

  1. Crown Bioscience Inc (JSR life science)
  2. Genedata AG
  3. Biognos AB
  4. Dassault Systèmes
  5. Acellera
  • It provides understanding of the Europe, drug modelling software market landscape and identifies drug modelling software market segments that are most likely to guarantee a strong return.

  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe drug modelling software market.

  • It helps efficiently plan merger and acquisition, and partnership deals in the drug modelling software market by identifying market segments with the most promising probable sales.

  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of drug modelling software market performance of various segments pertaining to the Europe drug modelling software market.

  • It provides drug modelling software market revenue forecast of the market based on various segments for the period from 2019 to 2027.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription